Skip to main content
. 2022 Jun 30;11(7):1313. doi: 10.3390/antiox11071313

Figure 2.

Figure 2

The viability assay of LX-2 and U937 cells according to bromide 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay after treatment for 24 h with 0, 35, 75, and 150 μg/mL of MLE. Bars represent the mean ± SEM. * p < 0.5 versus control (CTRL).